Immunotherapy Prevents Bowel Cancer Recurrence in TrialOctober 10, 2026 Health 0 Views Patients with high-risk bowel cancer remained free of recurrence for nearly three years after receiving immunotherapy before surgery, according to the NEOPRISM-CRC trial.
